Product Information

BUDESONIDE EC 3 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.5193 per EA under NDC 65162077810. Its NADAC has been published 459 times since Feb 7, 2018.

FDA first approved this application on Jul 31, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUDESONIDE EC 3 MG CAPSULE

Budesonide
$0.5193per EA

Strength

3 mg/1

NDC

65162077810

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUDESONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206200

FDA Approved

7/31/2017

TE Code

AB

On Market Since

9/15/2017

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BUDESONIDE EC 3 MG CAPSULE has been published 459 times since Feb 7, 2018, and over the history we have for it it has declined 89.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5193 per EA
All-time high$5.3364 (Mar 14, 2018)
All-time low$0.4242 (Nov 20, 2024)
52-week high$0.5230
52-week low$0.4975
Median price$0.7875
Average price$1.2046
Largest weekly change-35.6% (Apr 22, 2020)
Weeks tracked459
Tracking sinceFeb 7, 2018

Price History

1W

+0.2%

1M

+4.4%

3M

+4.1%

6M

-0.3%

1Y

+2.3%

3Y

-19.9%

5Y

-41.6%

All

-89.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUDESONIDE EC 3 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE EC 3 MG CAPSULE, manufactured by Amneal Pharmaceuticals LLC, is $0.5193 per EA (NDC 65162077810), effective Nov 18, 2026.

How has the price of BUDESONIDE EC 3 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUDESONIDE EC 3 MG CAPSULE has declined 89.3%. It has been tracked across 459 weekly CMS publications since Feb 7, 2018.

What are the highest and lowest recorded NADAC prices for BUDESONIDE EC 3 MG CAPSULE?

Since Feb 7, 2018, the NADAC for BUDESONIDE EC 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $5.3364 (Mar 14, 2018), with a median of $0.7875 per EA.

Are there cheaper alternatives to BUDESONIDE EC 3 MG CAPSULE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE EC 3 MG CAPSULE, is $0.5154 per EA — about 1% below BUDESONIDE EC 3 MG CAPSULE.

Who manufactures BUDESONIDE EC 3 MG CAPSULE?

BUDESONIDE EC 3 MG CAPSULE (NDC 65162077810) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.